Prevent Severe RSV with Arexvy Vaccine: Expert Tips for Seniors

Singapore has approved a vaccine for the respiratory syncytial virus ( RSV ) for individuals aged 60 and above . The vaccine , known as Arexvy , was developed by GSK and protects against lower respiratory tract disease caused by RSV . The Health Sciences Authority gave its approval on May 10 , making it the first vaccine for the virus available in Singapore . The vaccine is available at some clinics , with prices ranging from 20 to 50 for a single dose.

RSV is a contagious virus that affects the lungs and respiratory airways , similar to other respiratory infections like influenza and the common cold . Symptoms include cough , fever , runny nose , body aches , and in severe cases , pneumonia and bronchiolitis . In 2019 , RSV infection led to an estimated 5.2 million cases of acute respiratory infection among adults aged 60 and above in industrialized countries , resulting in 470,000 hospitalizations and 33,000 in - hospital deaths.

Experts recommend that seniors , especially those with respiratory conditions , get vaccinated against RSV to prevent complications and severe cases . The vaccine has shown to prevent pneumonia , which can be critical for individuals with chronic lung disease or weakened immunity . Patients with heart or lung diseases are at a higher risk of severe RSV cases , with hospitalization risks surpassing that of Covid-19 and influenza.

While the vaccine can reduce morbidity and deaths associated with RSV , there are reports of a rare neurological condition called Guillain - Barre syndrome being linked to the vaccine . Despite this potential risk , getting vaccinated is crucial in preventing severe cases that could lead to death or permanent disability . By getting vaccinated , individuals can protect themselves and reduce the impact of RSV on their health and lifestyle.

In conclusion , the availability of the Arexvy vaccine in Singapore provides a new tool in the fight against RSV for older individuals . Vaccination is recommended to lower the risks associated with severe RSV infection , especially for those with underlying health conditions . While there may be risks associated with the vaccine , the benefits of protection far outweigh the potential consequences of contracting the virus . It is essential for individuals to consult with healthcare professionals to determine the best course of action regarding vaccination against RSV.